Villin1, a diagnostic marker for endometrial adenocarcinoma with high grade nuclear atypia

Cancer Biology and Therapy

Volumn 12, Issue 3, 2011, Pages 181-190

  Nakamura, Etsuko ^a   Satoh, Toyomi ^b   Iwakawa, Mayumi ^a   Nakawatari, Miyako ^a   Oki, Akinori ^b   Matsumoto, Koji ^b   Okada, Satoshi ^b   Minaguchi, Takeo ^b   Yoshikawa, Hiroyuki ^b   Imai, Takashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adenocarcinoma; Cervical cancer; Endometrial cancer; EpCAM; Immunohistochemistry; VIL1

Indexed keywords

BIOLOGICAL MARKER; CD44V ANTIGEN; CELL SURFACE MARKER; EPITHELIAL CELL ADHESION MOLECULE; PROTEIN VILLIN1; TUMOR MARKER; UNCLASSIFIED DRUG; VILLIN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL EXAMINATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE GENITAL TRACT TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MESENCHYMAL STEM CELL; UTERINE CERVIX TUMOR; UTERUS CANCER;

ACTINS; ADENOCARCINOMA; AGED; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CYTOPLASM; CYTOSKELETON; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROFILAMENT PROTEINS; MIDDLE AGED; RADIATION TOLERANCE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 79961213973     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.3.15964     Document Type: Article

References (28)

1. Ushijima K. Current status of gynecologic cancer in Japan. J Gynecol Oncol 2009; 20:67-71; DOI: 10.3802/jgo.2009.20.2.67.
2. Report from gynecologic tumor committee of JSOG. Acta Obstet Gynaecol Jpn 2007; 59:952.
3. Sorosky JI. Endometrial cancer. Obstet Gynecol 2008; 111:436-47; DOI: 10.1097/AOG.0b013e318162f690.
4. dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol 2007; 107:458-63; DOI: 10.1016/j.ygyno.2007.07.080.
5. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol 2000; 78:97-105; DOI: 10.1006/gyno.2000.5826.
6. Nakamura E, Iwakawa M, Furuta R, Ohno T, Satoh T, Nakawatari M, et al. Villin1, a novel diagnostic marker for cervical adenocarcinoma. Cancer Biol Ther 2009; 8:1146-53; DOI: 10.4161/cbt.8.12.8477.
7. Khurana S, George SP. Regulation of cell structure and function by actin-binding proteins: Villin's perspective. FEBS Lett 2008; 582:2128-39; DOI: 10.1016/j.febslet.2008.02.040.
8. Ismail SM. Histopathological challenges in the diagnosis of endometrial hyperplasia and carcinoma. Curr Diagn Pathol 2006; 12:312-24; DOI: 10.1016/j.cdip.2006.06.002.
9. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study. Cancer 1995; 75:81-6; DOI: 10.1002/1097-0142(19950101)75: 1⟨81::AID-CNCR2820750114⟩3.0.CO;2-F.
10. Kurman RJ, McConnell TG. Precursors of endometrial and ovarian carcinoma. Virchows Arch 2010; 456:1-12; DOI: 10.1007/s00428-009-0824-9.
11. Izadi-Mood N, Sarmadi S, Sanii S. Strategies in the histologic diagnosis of low-grade glandular endometrial neoplasm. Curr Opin Obstet Gynecol 2010; 22:43-50; DOI: 10.1097/GCO.0b013e328332d0ff.
12. Seeberger KL, Eshpeter A, Rajotte RV, Korbutt GS. Epithelial cells within the human pancreas do not coexpress mesenchymal antigens: epithelial- mesenchymal transition is an artifact of cell culture. Lab Invest 2009; 89:110-21; DOI: 10.1038/labinvest.2008.122.
13. Nakawatari M, Iwakawa M, Ohno T, Kato S, Tamaki T, Imadome K, et al. Chemoradiation-induced expression of fibroblast growth factor-2 and laminin in patients with cervical cancer. Cancer Biol Ther 2007; 6:1780-6; DOI: 10.4161/cbt.6.11.4858.
14. Wang Y, Srinivasan K, Siddiqui MR, George SP, Tomar A, Khurana S. A novel role for villin in intestinal epithelial cell survival and homeostasis. J Biol Chem 2008; 283:9454-64; DOI: 10.1074/jbc.M707962200.
15. Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic and tissue array profiling. Cancer Res 2003; 63:5243-50. (Pubitemid 37139837)
16. Roth U, Razawi H, Hommer J, Engelmann K, Schwientek T, Müller S, et al. Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma. Proteomics 2010; 10:194-202; DOI: 10.1002/pmic.200900614.
17. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355:1404-11; DOI: 10.1016/S0140-6736(00)02139-5.
18. Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006; 106:804-11; DOI: 10.1002/cncr.21649.
19. Gemer O, Uriev L, Voldarsky M, Gdalevich M, Ben- Dor D, Barak F, et al. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer. Eur J Surg Oncol 2009; 35:247-51; DOI: 10.1016/j.ejso.2008.07.010.
20. Okuda T, Sekizawa A, Purwosunu Y, Nagatsuka M, Morioka M, Hayashi M, et al. Genetics of endometrial cancers. Obstet Gynecol Int 2010; 2010:984013.
21. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW, Zoeller M. CD44 and EpCAM: cancerinitiating cell markers. Curr Mol Med 2008; 8:784-804; DOI: 10.2174/156652408786733667.
22. Anders M, Sarbia M, Grotzinger C, Meining A, Hofler H, Wiedenmann B, et al. Expression of EpCam and villin in Barrett's esophagus and in gastric cardia. Dis Markers 2008; 24:287-92.
23. Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, et al. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 2009; 15:4299-311; DOI: 10.1158/1078-0432.CCR-08-1883.
24. Toki N, Kagami S, Kurita T, Kawagoe T, Matsuura Y, Hachisuga T, et al. Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance. Virchows Arch 2010; 456:387-93; DOI: 10.1007/s00428-010-0895-7.
25. Wang Y, Liu VW, Xue WC, Tsang PC, Cheung AN, Ngan HY. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol Oncol 2005; 98:104-10; DOI: 10.1016/j.ygyno.2005.04.015.
26. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Mol Aspects Med 2010; 31:145-70; DOI: 10.1016/j.mam.2010.02.008.
27. Imadome K, Iwakawa M, Nojiri K, Tamaki T, Sakai M, Nakawatari M, et al. Upregulation of stress-response genes with cell cycle arrest induced by carbon ion irradiation in multiple murine tumors models. Cancer Biol Ther 2008; 7:208-17; DOI: 10.4161/cbt.7.2.5255.
28. Matsumoto Y, Iwakawa M, Furusawa Y, Ishikawa K, Aoki M, Imadome K, et al. Gene expression analysis in human malignant melanoma cell lines exposed to carbon beams. Int J Radiat Biol 2008; 84:299-314; DOI: 10.1080/ 09553000801953334.